Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -23.80% is 18% below its 5-year average of -20.09%, near the high end of its 5-year range (-103.49%–-8.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.63% above its 12-month average of -60.44%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -23.80%.
RETURN ON INVESTED CAPITAL (ROIC)
-23.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-60.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-45.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-20.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-49.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-54.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+60.63%
CURRENT VS 3Y AVG
+47.16%
CURRENT VS 5Y AVG
-18.45%
CURRENT VS 10Y AVG
+51.96%
CURRENT VS 15Y AVG
+56.16%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+33.24%
vs the sector median at left
Pacific Biosciences of California, Inc.
Market Cap
$831.79M
Return on Invested Capital (ROIC)
-23.80%
TTM Avg
-60.44%
3Y Avg
-45.03%
5Y Avg
-20.09%
Market Cap
$817.67M
Return on Invested Capital (ROIC)
-7.99%
TTM Avg
-8.85%
3Y Avg
-21.37%
5Y Avg
-42.56%
Market Cap
$816.13M
Return on Invested Capital (ROIC)
-37.39%
TTM Avg
-65.53%
3Y Avg
-61.64%
5Y Avg
-93.68%
Market Cap
$833.81M
Return on Invested Capital (ROIC)
-28.69%
TTM Avg
-21.44%
3Y Avg
-33.52%
5Y Avg
-49.04%
Market Cap
$838.16M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
Market Cap
$804.16M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
Market Cap
$828.48M
Return on Invested Capital (ROIC)
-26.54%
TTM Avg
-38.64%
3Y Avg
-38.64%
5Y Avg
-38.64%
Market Cap
$789.34M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
Market Cap
$855.38M
Return on Invested Capital (ROIC)
-94.76%
TTM Avg
-114.06%
3Y Avg
-144.57%
5Y Avg
-144.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | $831.79M | -23.80% | -60.44% | -45.03% | -20.09% |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -7.99% | -8.85% | -21.37% | -42.56% |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | -37.39% | -65.53% | -61.64% | -93.68% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | -28.69% | -21.44% | -33.52% | -49.04% |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | -31.17% | -29.64% | -85.48% | -85.48% |
| InMode Ltd. (INMD)vs › | $804.16M | 9.20% | 13.08% | 19.17% | 23.78% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $828.48M | -26.54% | -38.64% | -38.64% | -38.64% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | -9.77% | 8.57% | -11.39% | -51.99% |
| Alumis Inc. (ALMS)vs › | $855.38M | -94.76% | -114.06% | -144.57% | -144.57% |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | -0.26% | 4.90% | -0.53% | 1.15% |
ROIC
-23.8%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -23.80% |
| 2026-03-31 | -22.69% |
| 2025-12-31 | -75.90% |
| 2025-09-30 | -89.59% |
| 2025-06-30 | -90.23% |
| 2025-03-31 | -103.49% |
| 2024-12-31 | -39.72% |
| 2024-09-30 | -29.41% |
| 2024-06-30 | -29.85% |
| 2024-03-31 | -20.32% |
| 2023-12-31 | -20.25% |
| 2023-09-30 | -19.48% |
| 2023-06-30 | -20.69% |
| 2023-03-31 | -19.68% |
| 2022-12-31 | -20.40% |
| 2022-09-30 | -16.39% |
| 2022-06-30 | -15.89% |
| 2022-03-31 | -13.56% |
| 2021-12-31 | -10.86% |
| 2021-09-30 | -8.58% |
| 2021-06-30 | -9.95% |
| 2021-03-31 | -8.64% |
| 2020-12-31 | -27.80% |
| 2020-09-30 | -57.82% |
| 2020-06-30 | -123.53% |
| 2020-03-31 | -100.32% |
| 2019-12-31 | -87.66% |
| 2019-09-30 | -98.75% |
| 2019-06-30 | -78.44% |
| 2019-03-31 | -67.43% |
| 2018-12-31 | -67.36% |
| 2018-09-30 | -54.43% |
| 2018-06-30 | -76.48% |
| 2018-03-31 | -68.51% |
| 2017-12-31 | -73.73% |
| 2017-09-30 | -66.76% |
| 2017-06-30 | -56.81% |
| 2017-03-31 | -73.63% |
| 2016-12-31 | -68.43% |
| 2016-09-30 | -45.92% |
| 2016-06-30 | -27.50% |
| 2016-03-31 | -23.58% |
| 2015-12-31 | -26.68% |
| 2015-09-30 | -57.18% |
| 2015-06-30 | -98.68% |
| 2015-03-31 | -94.01% |
| 2014-12-31 | -67.56% |
| 2014-09-30 | -66.99% |
| 2014-06-30 | -73.29% |
| 2014-03-31 | -58.08% |
| 2013-12-31 | -68.24% |
| 2013-09-30 | -60.27% |
| 2013-06-30 | -71.22% |
| 2013-03-31 | -69.29% |
| 2012-12-31 | -82.08% |
| 2012-09-30 | -70.75% |
| 2012-06-30 | -65.86% |
| 2012-03-31 | -58.43% |
| 2011-12-31 | -55.17% |
| 2011-09-30 | -56.99% |
| 2011-06-30 | -56.24% |
| 2011-03-31 | -56.94% |
| 2010-12-31 | -49.20% |
| 2010-09-30 | -122.92% |
| 2010-06-30 | -84.47% |
